The correlation between asthma control and health status: the GOAL study

The present study examined the association between guideline-derived asthma control and health-related quality of life, assessed using the Asthma Quality of Life Questionnaire (AQLQ), in patients with uncontrolled asthma whose treatment was directed towards achieving the highest possible level of control. The present randomised, double-blind, parallel-group study compared the efficacy of fluticasone propionate (FP) and salmeterol/fluticasone propionate combination (SFC) in achieving two composite, guideline-derived measures of control: total control (TC) and well-controlled (WC) asthma. Not achieving these levels was classed as not well-controlled (NWC). Doses were augmented until patients achieved TC or reached the maximum dose. This dose was maintained for the remainder of the study. AQLQ was assessed at baseline and at each clinic visit. AQLQ scores improved throughout the study, reaching near-maximal levels in patients achieving TC and WC, and 52-week mean scores in the three control groups were statistically significantly different. Clinically meaningful improvements (mean change from baseline) were: TC group (SFC 1.9, FP 1.8), WC (SFC 1.5, FP 1.5) and NWC (SFC 1.0, FP 0.9). In conclusion, the treatment aimed at controlling asthma improves the health-related quality of life to levels approaching normal. The difference in Asthma Quality of Life Questionnaire scores between total control and well-controlled confirms that patients distinguish even between these high levels of control.

[1]  Linda Abetz,et al.  Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire. , 2006, Respiratory medicine.

[2]  J. C. Carranza Rosenzweig,et al.  The relationship between health-related quality of life, lung function and daily symptoms in patients with persistent asthma. , 2004, Respiratory medicine.

[3]  R. Pauwels,et al.  Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. , 2004, American journal of respiratory and critical care medicine.

[4]  E. Juniper,et al.  The impact of patient compliance on effective asthma management , 2003, Current opinion in pulmonary medicine.

[5]  K. Ederle.  Improved control of asthma symptoms with a reduced dose of HFA-BDP extrafine aerosol: an open-label, randomised study. , 2003, European review for medical and pharmacological sciences.

[6]  C. van Weel,et al.  Self-management of asthma in general practice, asthma control and quality of life: a randomised controlled trial , 2003, Thorax.

[7]  E. Yelin,et al.  Perceived control of asthma and quality of life among adults with asthma. , 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[8]  E. Bateman,et al.  Achieving guideline-based asthma control: does the patient benefit? , 2002, European Respiratory Journal.

[9]  D. Price,et al.  Clinically important improvements in asthma-specific quality of life, but no difference in conventional clinical indexes in patients changed from conventional beclomethasone dipropionate to approximately half the dose of extrafine beclomethasone dipropionate. , 2002, Chest.

[10]  D. Grimley,et al.  UNDERSTANDING PATIENT PERCEPTIONS OF ASTHMA: RESULTS OF THE ASTHMA CONTROL AND EXPECTATIONS (ACE) SURVEY , 2002, International journal of clinical practice.

[11]  P. Jones.  Interpreting thresholds for a clinically significant change in health status in asthma and COPD , 2002, European Respiratory Journal.

[12]  G. Crompton,et al.  Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. , 2001, The European respiratory journal.

[13]  J. Bousquet,et al.  Is overall asthma control being achieved? A hypothesis-generating study. , 2001, The European respiratory journal.

[14]  D. Postma,et al.  Asthma quality of life during 1 year of treatment with budesonide with or without formoterol. , 1999, The European respiratory journal.

[15]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[16]  G H Guyatt,et al.  Determining a minimal important change in a disease-specific Quality of Life Questionnaire. , 1994, Journal of clinical epidemiology.

[17]  Alfred O. Berg,et al.  Clinical Guidelines And Primary Care Guidelines For The Diagnosis And Management Of Asthma , 2012 .

[18]  G. Guyatt,et al.  Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. , 1992, Thorax.